Demystifying breast cancer.
作者信息
Wilkinson Anna N
机构信息
Associate Professor in the Department of Family Medicine at the University of Ottawa in Ontario, a family physician with the Ottawa Academic Family Health Team, a general practitioner oncologist at the Ottawa Hospital Cancer Centre, Program Director of PGY-3 FP-Oncology, and Regional Cancer Primary Care Lead for Champlain Region.
出版信息
Can Fam Physician. 2023 Jul;69(7):473-476. doi: 10.46747/cfp.6907473.
Abstract
摘要
相似文献
1
Demystifying breast cancer.揭开乳腺癌的神秘面纱。
Can Fam Physician. 2023 Jul;69(7):473-476. doi: 10.46747/cfp.6907473.
2
[Combined surgical-radiological therapy of cancer of the female breast].[女性乳腺癌的手术-放射联合治疗]
Klin Med Osterr Z Wiss Prakt Med. 1962 Jun;17:372-6.
3
Demystifying basal-like breast carcinomas.解读基底样乳腺癌
J Clin Pathol. 2007 Dec;60(12):1328-32. doi: 10.1136/jcp.2006.041731. Epub 2007 May 11.
4
Progress in the treatment of female breast cancer since 1955. II.1955年以来女性乳腺癌的治疗进展。II.
Rev Surg. 1962 Jul-Aug;19:217-39.
5
"Protective" colostrum in the treatment of patients with advanced breast cancer.“保护性”初乳在晚期乳腺癌患者治疗中的应用
Arch Surg. 1960 Dec;81:997-1004. doi: 10.1001/archsurg.1960.01300060143027.
6
The endocrine palliation of the breast cancer patient.乳腺癌患者的内分泌姑息治疗。
J Maine Med Assoc. 1960 Dec;51:433-8.
7
Massive estrogen administration in premenopausal women with advanced breast cancer.对患有晚期乳腺癌的绝经前女性大量施用雌激素。
Cancer Chemother Rep. 1962 Feb;16:283-4.
8
Demystifying care of patients with radioactive implants.揭开放射性植入物患者护理的神秘面纱。
Am J Nurs. 1985 Jul;85(7):788-92.
9
[Current status of the treatment of carcinoma of the breast].[乳腺癌的治疗现状]
Dia Med. 1948 May 31;20(26):956-36.
10
[On the treatment as well as the recovery results in breast cancer in women].[关于女性乳腺癌的治疗及康复结果]
Geburtshilfe Frauenheilkd. 1960 Sep;20:1007-19.
引用本文的文献
1
Synergistic bioinformatics and sophisticated machine learning unveil ferroptosis-driven regulatory pathways and immunotherapy potential in breast carcinoma.协同生物信息学和先进的机器学习揭示了乳腺癌中铁死亡驱动的调控途径和免疫治疗潜力。
Discov Oncol. 2025 May 4;16(1):668. doi: 10.1007/s12672-025-02393-7.
2
Cancer survivorship road map.癌症幸存者路线图。
Can Fam Physician. 2024 Jul-Aug;70(7-8):465-468. doi: 10.46747/cfp.700708465.
3
Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses.基于脂质体的纳米药物递送系统用于乳腺癌治疗：最新进展。
Anticancer Agents Med Chem. 2024;24(12):896-915. doi: 10.2174/0118715206293653240322041047.
4
Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing.捕获乳腺癌治疗的真实成本：基于分子亚型和分期的每例活动成本核算。
Curr Oncol. 2023 Aug 26;30(9):7860-7873. doi: 10.3390/curroncol30090571.
5
The family physician: Jack of all trades, master of integration.家庭医生：万事通，整合高手。
Can Fam Physician. 2023 Jul;69(7):450. doi: 10.46747/cfp.6907450.
本文引用的文献
1
Radiation Therapy for Low-Risk Breast Cancer: Whole, Partial, or None?低危乳腺癌的放射治疗：全乳、部分还是不治疗？
J Clin Oncol. 2022 Dec 20;40(36):4166-4172. doi: 10.1200/JCO.22.01751. Epub 2022 Nov 4.
2
Treatment Strategies for Residual Disease following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer.新辅助化疗后早期乳腺癌患者残留病灶的治疗策略。
Curr Oncol. 2022 Aug 16;29(8):5810-5822. doi: 10.3390/curroncol29080458.
3
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.Sacituzumab Govitecan 治疗转移性三阴性乳腺癌。
N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485.
4
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).阿贝西利联合内分泌治疗用于 HR+、HER2-、淋巴结阳性、高危、早期乳腺癌的辅助治疗（monarchE）。
J Clin Oncol. 2020 Dec 1;38(34):3987-3998. doi: 10.1200/JCO.20.02514. Epub 2020 Sep 20.
5
Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges.三阴性乳腺癌的新辅助治疗：最新进展与挑战
Cancers (Basel). 2020 May 29;12(6):1404. doi: 10.3390/cancers12061404.
6
Therapy-induced cardiotoxicity in breast cancer patients: a well-known yet unresolved problem.乳腺癌患者的治疗引起的心脏毒性：一个众所周知但尚未解决的问题。
Discoveries (Craiova). 2019 Mar 31;7(1):e89. doi: 10.15190/d.2019.2.
7
Pembrolizumab for Early Triple-Negative Breast Cancer.帕博利珠单抗治疗早期三阴性乳腺癌。
N Engl J Med. 2020 Feb 27;382(9):810-821. doi: 10.1056/NEJMoa1910549.
8
Overview of breast cancer.乳腺癌概述
JAAPA. 2019 Oct;32(10):13-17. doi: 10.1097/01.JAA.0000580524.95733.3d.
9
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.《第四届欧洲中学教育阶段（ESO）-欧洲肿瘤内科学会（ESMO）晚期乳腺癌国际共识指南（ABC 4）》† 。
Ann Oncol. 2018 Aug 1;29(8):1634-1657. doi: 10.1093/annonc/mdy192.
10
Mechanisms of therapeutic CDK4/6 inhibition in breast cancer.乳腺癌治疗性 CDK4/6 抑制的作用机制。
Semin Oncol. 2017 Dec;44(6):385-394. doi: 10.1053/j.seminoncol.2018.01.006.
Zotero 插件